Replies to post #670134 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

What is the current SOC? Chemo radiation.
How did NWBO conduct the nGBM trial? With initial concurrent Temodar and DCVax-l.

The Company’s approved PIP includes 2 clinical trials: one for newly diagnosed pediatric high grade glioma (HGG), and one for recurrent pediatric HGG. In each of the 2 pediatric trials, 24 patients will be treated with DCVax-L on the same treatment schedule as in the Company’s Phase III trial in adult glioblastoma patients.